Plain-English translation of NCT05765500 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a newer hormone treatment for prostate cancer, and comparing it head-to-head with , a hormone treatment that has been used for many years. The study wants to understand which treatment helps men maintain a better quality of life and allows their testosterone to recover faster after treatment ends.
Both treatments work by lowering testosterone to fight prostate cancer, but they have different ways of being given and may affect men's lives differently. This medication is newer, and doctors want to understand if it might be a better choice for some patients in terms of side effects, quality of life, and how quickly the body recovers after treatment.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either or for 6 months. If you get , you will take a pill at home every day for 6 cycles. If you get , you will receive injections in the clinic twice during the study. Either way, you will visit the clinic every 3 months for 12 months total, complete surveys about how you are feeling, have blood tests and heart monitoring, and keep a medication diary. The entire study lasts about one year.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States